Clinical and Economic Impact of Nirsevimab and Bivalent Maternal Vaccine Against RSV Infections in Infants in Italy
- DOI
- 10.2147/ceor.s622013
- Published
- 2026-11
- Container
- ClinicoEconomics and Outcomes Research
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2147/ceor.s622013,
title = {Clinical and Economic Impact of Nirsevimab and Bivalent Maternal Vaccine Against RSV Infections in Infants in Italy},
author = {Chiara Bini and Andrea Marcellusi and Barbara Muzii and Samira Soudani and Sara Trotta and Salvatore Parisi and Elena Bozzola and Paolo Bonanni and Sara Boccalini},
year = {2026},
journal = {ClinicoEconomics and Outcomes Research},
doi = {10.2147/ceor.s622013},
url = {https://doi.org/10.2147/ceor.s622013}
}RIS
TY - JOUR TI - Clinical and Economic Impact of Nirsevimab and Bivalent Maternal Vaccine Against RSV Infections in Infants in Italy AU - Chiara Bini AU - Andrea Marcellusi AU - Barbara Muzii AU - Samira Soudani AU - Sara Trotta AU - Salvatore Parisi AU - Elena Bozzola AU - Paolo Bonanni AU - Sara Boccalini PY - 2026 JO - ClinicoEconomics and Outcomes Research DO - 10.2147/ceor.s622013 UR - https://doi.org/10.2147/ceor.s622013 ER -
APA
Bini, C., Marcellusi, A., Muzii, B., Soudani, S., Trotta, S., Parisi, S., Bozzola, E., Bonanni, P., & Boccalini, S. (2026). Clinical and Economic Impact of Nirsevimab and Bivalent Maternal Vaccine Against RSV Infections in Infants in Italy. ClinicoEconomics and Outcomes Research. https://doi.org/10.2147/ceor.s622013
Source records
- crossref · retrieved 2026-11-09T13:05:16.537Z